marginal zone lymphoma

News

Bristol Myers Squibb has taken CAR-T therapy into new territory, after getting FDA approval for Breyanzi in marginal zone lymphoma.

News

HHS unveils an enforcement holiday to manufacture of unapproved peptides - before the FDA decides if they should be allowed in compounded medicines.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.